Mercedes-Benz USA, LLC
Summary
NHTSA campaign 21V072: Mercedes-Benz USA, LLC recalled for a safety defect. A disabled eCall system would prevent a vehicle occupant from contacting emergency services through the call center in a
Details
Source
nhtsa
External ID
21V072
Action Date
2021-02-16
Status
Ongoing
Category
vehicle
Product Description
Mercedes-Benz USA, LLC (MBUSA) is recalling certain 2017-2019 C300, E300, 2018-2020 CLA250, 2020 CLS450, AMG E53, AMG GT53, GLE450, 2018 AMG E63, AMG GTA, 2017-2020 GLA250, GLC300, 2019 GLC350, AMG GLC43, 2017-2018 GLE350, 2019 AMG GLC 43, GLC350, GLE400, 2017 GLS450, S550, C300 Cabrio, and 2018-2019 S560 vehicles. On June 18, 2021, an additional 9 vehicles were added, including certain 2021 GLA250, GLC300, 2018 S450, E400, and 2017 CLA250 vehicles. The communication module might have been inadvertently deactivated during a service visit, which could have disabled the Emergency Call (eCall) function.
Company
Context & Analysis
Mercedes-Benz USA, LLC has 149 FDA actions in our database.
Frequently Asked Questions
How often does Mercedes-Benz USA, LLC have FDA actions?
Mercedes-Benz USA, LLC has 149 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle